Coalition aims for increased U.S. colorectal cancer screening

This article originally appeared here.
Share this content:
Coalition Calls for Increased Colorectal Cancer Screening
Coalition Calls for Increased Colorectal Cancer Screening

(HealthDay News) -- Boosting older adults' colorectal cancer screening rates to 80 percent by 2018 would lead to 21,000 fewer deaths from the cancer each year in the United States by 2030, according to research published March 12 in Cancer.

Colorectal cancer is a leading cause of cancer death in the United States. Yet in 2013, only 58 percent of American adults aged 50 to 75 underwent recommended screening for it, the study authors said.

An initiative to get four out of five older adults screened for colorectal cancer by 2018 was recently launched by the cancer roundtable, a coalition of public, private, and volunteer organizations. Researchers used a computer model to estimate the potential benefits of 80 percent screening rates among adults aged 50 to 75.

That level of screening would reduce colorectal cancer incidence rates by 17 percent and death rates by 19 percent by 2020. Over the long term, greater gains were predicted, with new cases and deaths declining 22 and 33 percent, respectively, from 2013 through 2030. "The barriers to increasing colorectal cancer screening in the United States are significant and numerous," Richard Wender, M.D., chair of the National Colorectal Cancer Roundtable, said in a journal news release. "But this study shows that investing in efforts to clear these hurdles will result in a major cancer prevention success."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs